The Isotretinoin Purge and When It Ends

Does isotretinoin make acne worse before it gets better?

For a meaningful share of people, yes — an initial flare in the first few weeks of an isotretinoin course is common enough that it has its own informal name, the purge. Skin often looks more inflamed, with more visible whiteheads or cysts, before it starts to genuinely improve. This early worsening is a recognized part of the treatment course captured in the broader adverse-effect picture of isotretinoin trials 1Ref 1Costa CS, Bagatin E, Martimbianco ALC, et al. (2018).Oral isotretinoin for acne.The systematic evidence review of oral isotretinoin trials characterizes the drug's adverse-effect profile over the course of treatment, supporting that early treatment-emergent worsening is a recognized part of the picture., not a sign the medication isn't working.

The flare is temporary for the substantial majority of people who experience it, and it's not a reliable predictor of how well isotretinoin will ultimately clear the skin. Plenty of people skip the flare altogether and still see excellent results by the end of a course.

The word 'purge' itself is borrowed from skincare marketing around topical retinoids, where it describes something with a similar look but a somewhat different cause. Applied to isotretinoin, it's become the common shorthand for this early flare, even though isotretinoin is an oral medication working through the whole body rather than a topical acting only where it's applied.

Why the early flare happens

Isotretinoin's main effect is shrinking the oil glands and reducing oil production, but that effect isn't instant — it builds over the first several weeks of treatment. In the meantime, existing microscopic clogged pores that hadn't yet become visible breakouts can surface and become inflamed, which is part of why skin can look temporarily worse even as the medication starts working underneath.

This is different from an allergic reaction or a sign of worsening disease; it's closer to clearing out a backlog that was already forming before treatment started. It tends to be more noticeable in people who start at a higher dose or who had more subclinical congestion in their skin to begin with.

Skin cell turnover also speeds up early in treatment, which can temporarily leave skin drier and more sensitive at the same time it's dealing with the flare itself. That combination — more visible inflammation plus drier, more reactive skin — is part of why the first few weeks can feel disproportionately rough compared to how the rest of the course typically goes.

When the flare typically starts and ends

The purge most often begins in the first two to four weeks of a course and tends to peak somewhere around week four to six, before gradually improving. Mapping this onto an isotretinoin timeline, most people see clear improvement by month two or three, with the bulk of the visible clearing happening in the back half of a standard several-month course.

Not everyone follows this exact pattern — some people see minimal flaring and steady improvement from early on, while others have a more pronounced flare that takes a bit longer to settle. Both are within the normal range of how isotretinoin can play out, and neither pattern reliably predicts the other.

Starting dose plays some role in how the timeline unfolds: courses that begin at a lower dose and increase gradually sometimes produce a milder, later flare compared with courses that start closer to the eventual target dose right away. That's one of several reasons two people on isotretinoin for the same underlying acne can describe fairly different early experiences.

Does a worse flare mean a worse outcome, or a better one?

Neither, reliably. The intensity of the initial flare doesn't consistently predict how clear skin ends up by the end of a course, so a rough first month isn't a bad omen and a mild or absent flare isn't a warning sign either. Most flares settle on their own as treatment continues, without needing any change to the plan.

What does matter is whether the flare crosses into something that needs attention — new, unusually painful nodules, or a level of breakout that's causing real distress. That's a reasonable thing to raise with the prescriber managing the course, since occasionally a starting dose is adjusted specifically to make the early weeks more tolerable.

What happens if a flare leaves marks behind

A more severe flare occasionally leaves some scarring or dark marks behind, the same way a bad breakout would outside of an isotretinoin course. This is a separate concern from the flare itself, and it's usually addressed after the skin has fully settled rather than during the active flare.

Acne scar treatments, compared honestly, exist as a later option if marks remain once a course is finished — combination approaches using lasers, peels, microneedling, or subcision tend to outperform any single method on its own, though the evidence for exactly how much improvement to expect is still fairly limited 2Ref 2Boen M, Jacob C (2024).Atrophic Postacne Scar Treatment: Narrative Review.Combination approaches to atrophic acne scar treatment — lasers, peels, microneedling, and subcision — outperform single modalities, though evidence quality for expected improvement is limited.. That conversation is best had once the skin has stabilized, not in the middle of an active flare, since it's easier to judge what actually needs treating once the inflammation from the flare itself has settled down.

What the rest of the course looks like after the purge settles

Once the initial flare eases, most people see steady, gradual improvement for the remainder of the course, alongside the more familiar isotretinoin side effects — dryness, chapped lips, and sometimes joint aches — rather than the acne-specific worsening of the first weeks. Isotretinoin is generally reserved for acne that's severe, scarring, or resistant to other treatment 3Ref 3Reynolds RV, Yeung H, Cheng CE, et al. (2024).Guidelines of care for the management of acne vulgaris.Oral isotretinoin is strongly recommended for acne that is severe, scarring, psychosocially burdensome, or refractory, providing context for why someone would push through an early flare., which is part of why so many people push through an uncomfortable first month for the results in the months that follow.

Some prescribers start at a lower initial dose partly to blunt how sharp the early flare feels, an approach sometimes described as the case for low-dose isotretinoin, before adjusting upward. When acne returns after isotretinoin is a separate question with its own timeline — but the purge itself is a front-loaded, temporary chapter, not a preview of long-term relapse.